| DIRECT COMPETITOR COMPARISON | |
| PFE | BAYRY.PK | MRK | NVS | Industry | | Market Cap: | 149.53B | N/A | 76.82B | 124.35B | 128.76M | | Employees: | 81,800 | N/A | 55,200 | 99,000 | 181 | | Qtrly Rev Growth (yoy): | -2.90% | N/A | 1.80% | 2.40% | 14.60% | | Revenue (ttm): | 45.82B | N/A | 23.37B | 42.31B | 31.21M | | Gross Margin (ttm): | 86.61% | N/A | 76.36% | 72.61% | 72.39% | | EBITDA (ttm): | 21.31B | N/A | 7.81B | 11.24B | -1.66M | | Oper Margins (ttm): | 37.42% | N/A | 26.63% | 21.50% | -18.10% | | Net Income (ttm): | 8.09B | N/A | 8.05B | 7.59B | N/A | | EPS (ttm): | 1.204 | N/A | 3.808 | 3.34 | N/A | | P/E (ttm): | 15.39 | N/A | 9.56 | 16.39 | 13.61 | | PEG (5 yr expected): | 5.91 | 2.61 | 2.11 | 2.75 | 1.99 | | P/S (ttm): | 3.26 | N/A | 3.29 | 2.94 | 3.29 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.25 | 0.00% | 56.93B | 12.27 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.79 | 0.00% | 13.53B | 15.66 | | Genzyme Corp. | GENZ | 50.24 | 0.00% | 13.33B | 28.64 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 47.01 | 0.00% | 42.31B | 18.18 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.83 | 0.00% | 8.89B | 1016.94 | | Teva Pharmaceutical Industries Limited | TEVA | 53.43 | 0.00% | 47.07B | 48.88 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 35.55 | 0.00% | 3.77B | 18.32 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 12.06 | 0.00% | 2.99B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.98 | 0.00% | 5.49B | 110.31 | | Pfizer Inc. | PFE | 18.53 | 0.00% | 149.53B | 15.39 | | Johnson & Johnson | JNJ | 62.69 | 0.00% | 172.97B | 13.69 | | GlaxoSmithKline plc | GSK | 42.14 | 0.00% | 106.82B | 13.09 | | Sanofi-Aventis | SNY | 38.62 | 0.00% | 100.84B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 54.75 | 0.00% | 124.35B | 16.39 | | RHHBY.PK | 40.96 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 45.40 | 0.00% | 65.83B | 9.12 | | Abbott Laboratories | ABT | 53.13 | 0.00% | 82.18B | 14.39 | | Bristol-Myers Squibb Co. | BMY | 25.05 | 0.00% | 49.62B | 12.96 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | MRK | | Analysis Finds Vioxx's Heart Attack Risk in 2001
Mon 11:16pm -
at The Wall Street Journal Online | | • | NVS | | Lightning Round: AT&T, Verizon, Novartis and More
Mon 7:56pm -
at CNBC | | • | MRK | | Merck Wins Summary Judgment in Second Federal Bellwether Case Involving FOSAMAX® (alendronate sodium)
Mon 7:01pm -
Business Wire | | • | MRK | | 5 Stocks That Benefit from Health Care Legislation: Analysts
Mon 6:22pm -
at CNBC | | • | NVS | | [$$] 10 for the Money
Mon 5:24pm -
at Barrons.com | | • | MRK | | Merck, SPDR Gold: Money Flow Leaders (MRK, GLD)
Mon 4:56pm -
at The Wall Street Journal Online | | • | MRK | | UPDATE - US lawsuit over Merck bone drug Fosamax dismissed
Mon 4:30pm -
at Reuters | | • | MRK | | Vioxx Showed Risk Signs Before Being Pulled: Report
Mon 4:19pm -
at CNBC | | • | NVS | | [$$] Dividend Stocks Get a Boost
Mon 2:31pm -
at Barrons.com | | • | BAYRY.PK | | Biotech Stocks: Europe drug stocks rally; Cephalon slides
Mon 10:35am -
at MarketWatch | | • | NVS | | Now Is the Time to Buy Risk
Fri, Nov 20 -
at Motley Fool | | • | NVS | | Pfizer Dodges a Bullet
Thu, Nov 19 -
at Motley Fool | | • | NVS | | Pfizer's Generic Growth, With a Side of Sashimi
Thu, Nov 19 -
at Motley Fool | | • | BAYRY.PK | | UK health unit rejects Bayer drug as too expensive
Thu, Nov 19 -
at MarketWatch | | • | BAYRY.PK | | Oculus Wins China Approval for Animal Wound Product
Tue, Nov 17 -
at Seeking Alpha | | • | BAYRY.PK | | Trading Outlook for BioElectronics Corporation Issued by StockPreacher.com
Thu, Nov 12 -
GlobeNewswire | | • | BAYRY.PK | | CEO Interview: Aeolus Pharmaceuticals, Inc. - John L. McManus
Mon, Nov 2 -
Wall Street Transcript | | • | BAYRY.PK | | The World's Top Chemical Companies
Mon, Nov 2 -
at Seeking Alpha | | • | BAYRY.PK | | Bayer Disappoints
Wed, Oct 28 -
Zacks.com | | • | BAYRY.PK | | Bayer Earnings Call scheduled for 10:00 am ET today
Tue, Oct 27 -
CCBN | | | All Headlines for these symbols... |
|
|
|
1.29% Nasdaq 0.00%
Competitors
